Apoptosis, or programmed cell death, is a process crucial in organ development and homeostasis. Apoptotic cells are fragmented and form so-called apoptotic bodies that are engulfed and degraded by neighboring phagocytes. In order to engulf apoptotic cells, receptors on the phagocytes must recognize ligands expressed exclusively on apoptotic cells. Apoptosis induces several cellular changes, including membrane blebbing, condensation of chromatin along the nuclear membrane, and the generation of membrane-enclosed apoptotic bodies.
the American Type Culture Collection (ATCC, U.S.A.), and cells of the human monocytic cell line THP-1 were obtained from the Japanese Collection of Research Bioresources (JCRB, Japan). HT-29 cells were maintained in Dulbecco's MEM supplemented with 10% FBS, 0.3 mg/ml glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin at 37°C under 5% CO 2 in air. THP-1 cells were maintained in RPMI-1640 under similar conditions.
Induction of Apoptosis in HT-29 Cells Induction of apoptosis was performed using a slight modification of the procedure described by Akamatsu and colleagues. 15) Briefly, HT-29 cells were incubated with 100 U/ml of IFN-g for 24 h. After incubation with IFN-g, HT-29 cells were incubated with 50 ng/ml of anti-Fas antibody for 24 h without removal of IFN-g.
Measurement of Cell Viability and Apoptotic Cells An estimation of cell viability was performed using the trypan blue dye exclusion test. To detection of DNA fragmented apoptotic cell, cells were stained with propidium iodide solution (50 mg/ml) in 0.1% sodium citrate as described by Krishan. 16) Samples were kept at 4°C in the dark, and the cell cycle population was analyzed using a Cyto ACE-300 flow cytometer (JASCO, Tokyo). A percent of apoptotic cell was defined as the percentage of cells with hypodipoid DNA content (less DNA than those in G0/G1 phase) to total population.
Analysis of Cell Surface Molecules Changes in the cell surface PS and sugar chains in anti-Fas antibody-treated HT-29 cells were analyzed by flow cytometry. In the PS analysis, the cells were stained with FITC-conjugated Annexin V (a Ca 2ϩ -dependent, phospholipid-binding protein with high affinity for PS), according to the manufacturer's instructions. In the sugar chain analysis, the cells were stained with biotinconjugated lectins: AAL for fucose, RCA for galactose, Con A for mannose, and FITC-conjugated avidin as described previously. 8) Each cell suspension was analyzed using a flow cytometer.
Preparation of Macrophages THP-1 cells were differentiated into macrophages by treatment with 100 ng/ml of PMA for 72 h. PMA-treated THP-1 cells were adherent to the culture plates and showed high nitro-blue tetrazolium (NBT) reducibility. They were washed with phosphate buffered saline (PBS) three times before phagocytosis assay.
Preparation of Liposomes Liposomes containing PS or PC were prepared using a slight modification of the procedure described by Fadok and coworkers. 17) PS and PC suspended in chloroform/methanol (9/1) were added to glass tubes (PC liposomes were made at 100% PC, PS liposomes made at 70% PC/30% PS); the solvent was evaporated under N 2 gas, and the lipids were resuspended in HEPES buffer (10 mM HEPES/NaOH pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ) by vortexing. The mixtures were subsequently sonicated for 5 min on ice. Prepared liposomes were suspended in medium for use in the inhibitory assay of phagocytosis.
Phagocytosis Assay Flow cytometric phagocytosis assays were performed according to the method described by Hess and colleagues. 18 ) 5ϫ10 5 apoptotic HT-29 cells/ml were incubated with 50 ng/ml TAMRA for 15 min at 37°C. TAMRA-stained apoptotic HT-29 cells were washed with PBS three times and phagocytosed by PMA-treated THP-1 cells. A 10-fold amount of apoptotic HT-29 cells were added to confluent PMA-treated THP-1 cells and incubation for 2 h at 37°C. Inhibitors were included directly in the medium (at the concentrations given below or in the figure legends). After phagocytosis, culture medium was removed and adherent cells were washed PBS three times and treated with 0.02% EDTA/PBS for 5 min to dissociate the monolayers and create a single cell suspension. These macrophage-like cells were analyzed using a flow cytometer and the proportion of phagocytic cells (which show a higher fluorescence intensity than non-phagocytic macrophages) was calculated to determine the phagocytosis ratio. Results of obtained from this method correlated well with the percentage of macrophage like cells that ingested one or more apoptotic cells by light microscopy (rϭ0.991).
Modification of Non-apoptotic HT-29 Cells HT-29 cells expressing high levels of PS were prepared by incubating HT-29 cells with 1 mM of N-ethylmaleimide (NEM) for 6 min at 37°C, followed by three washes with PBS. Asialo HT-29 cells were prepared by incubating HT-29 cells with 50 mU/ml of neuraminidase for 1 h at 37°C, followed by three washes with PBS. Asialo-agalacto HT-29 cells were prepared by incubating asialo HT-29 cells with 5 mU/ml bgalactosidase for 1 h at 37°C, followed by three washes with PBS.
RESULTS

Changes of Cell Surface Molecules in Apoptotic HT-29 Cells
After preincubation with IFN-g (100 U/ml) for 24 h, HT-29 cells were treated with anti-Fas antibody (50 ng/ml). As shown in Fig. 1A , cell viability of anti-Fas antibodytreated HT-29 cells decreased with the increase in DNA fragmented apoptotic cells. These findings were not observed when the cells were treated only with IFN-g or anti-Fas antibody (data not shown). Therefore, HT-29 cells treated with both IFN-g and anti-Fas antibody were considered to be undergoing the process of apoptosis.
During apoptosis, cell surface molecules such as PS and carbohydrates were changed. PS, which is normally almost totally confined to the inner leaflet of the plasma membrane, moves transversely across the bilayer to the outer leaflet of the plasma membrane in early apoptosis (Fig. 1B) .
Changes in the expression of carbohydrate antigens on the HT-29 cell surface associated with apoptosis were examined by flow cytometric analysis. As shown in Fig. 1C , enhanced expression of galactose binding to RCA with the decrease in expression of sialic acids binding to LFA and fucose binding to AAL were observed on the cell surface of the anti-Fas antibody-treated HT-29 cells, though no change was observed for mannose binding to ConA. We classified the apoptotic process into three phases by changes in cell surface molecules, that is, the initial phase: 0-6 h after anti-Fas antibody treatment, characterized by enhanced expression of PS without changes in cell viability, apoptotic cells and galactose; the metaphase: 6-18 h after anti-Fas antibody treatment, characterized by high levels of expression of apoptotic cells, PS and galactose with a slight decrease in cell viability; and the later phase: 18-24 h after anti-Fas antibody treatment, characterized by high levels of expression of apoptotic cells, PS and galactose with low cell viability.
Inhibition of Phagocytosis by Monosaccharides, PS Li-posomes, and RDGS In order to clarify the involvement of individual cellular molecules in the phagocytosis of apoptotic cells, the effect of each inhibitor was analyzed in each phase. The human monocytic cell line THP-1 is known to acquire increased phagocytic ability by treatment with PMA. 19) We treated THP-1 cells with PMA and used them in a phagocytosis assay as macrophage-like cells. Apoptotic cells are specifically recognized by the PS receptor, lectins, and the vitronectin receptor, and these receptors can be blocked by PS liposomes, monosaccharides, and RGDS peptide, respectively. Thus, 50 mM PS liposomes, PC liposomes (control liposomes) or 50 mM galactose, mannose, fucose, or 1 mM RGDS, RGES (control peptide) were added to the phagocytosis assay system for inhibition experiments. In this study, apoptotic cells in three phases revealed almost similar phagocytosis (non-apoptotic control: 6.5%; initial phase (4 h): 52.0%; metaphase (12 h): 55.7%; later phase (24 h): 56.9%). In the initial phase and metaphase, PS liposomes, galactose, and RGDS inhibited about 20% of the phagocytosis of apoptotic cells, and in the later phase, PS liposomes and galactose inhibited the phagocytosis of these cells, but RGDS did not (Table 1) . PC liposomes and RGES were not affect the phagocytosis of apoptotic cells in every phases. It was suggested that PS and galactose on sugar chains related to the phagocytosis of apoptotic cells in every stage, and vitronectin was only involved in the early stage of apoptosis. Furthermore, as shown in Table 1 , the combination of PS liposomes and galactose enhanced inhibitory effects (33% of the phagocytosis), suggesting that PS and galactose cooperated in the phagocytosis of apoptotic cells.
Phagocytosis of Modified Non-apoptotic HT-29 Cells
The above results suggested that PS externalization is responsible for the phagocytosis of apoptotic cells by macrophages. Thus, we studied whether PS externalization can trigger phagocytosis independent of apoptosis. We treated HT-29 cells with NEM to cause externalization of PS without induction of apoptosis. NEM-treated HT-29 cells were highly reactive to annexin V, which binds to PS, but were not changed in their binding to lectins (LFA and RCA) (Fig. 2) . NEM-treated HT-29 cells were phagocytosed by macrophages, although the amount of phagocytosis was lower than that for HT-29 cells induced to undergo apoptosis with anti-Fas antibody (Fig. 3) . In addition, these processes were inhibited by PS-liposomes to control levels (Fig. 3) , suggesting that PS plays an important role in the phagocytosis of apoptotic cells.
In the study of the inhibitory effect of monosaccharides, galactose inhibited phagocytosis, but fucose and mannose did not. Thus, we studied the effect of exposure to galactose to clarify the implication of galactose in the phagocytosis of apoptotic cells. HT-29 cells were exposed to galactose by neuraminidase treatment without induction of apoptosis, and a decrease in sialic acid moieties (which bind to LFA) and an increase in galactose moieties (which bind to RCA) were observed (Fig. 2) , indicating that sialic acids on HT-29 cells were released to expose galactose by neuraminidase treatment. These modified HT-29 cells were also phagocytosed by macrophages, though phagocytosis was less effective than for apoptotic HT-29 cells (Fig. 3) . These processes were inhibited by the combined treatment of HT-29 cells with galactosidase and neuraminidase (Fig. 3) . It was suggested that galactose also played an important role in the phagocytosis of In addition, since PS liposomes and galactose revealed additional inhibitory effects on phagocytosis (Table 1) , we studied the phagocytosis of NEM-and neuraminidase-treated HT-29 cells to investigate the cooperation between PS and galactose on the cell surface in the phagocytosis of apoptotic cells. As shown in Fig. 2 , in spite of NEM-and neuraminidase-treated HT-29 cells expressed PS and galactose as high as anti-Fas Ab-treated HT-29 cells, these cells revealed that the level of phagocytosis is equivalent to that of NEMtreated cells (Fig. 3) . These results suggested that PS and galactose did not cooperate in the phagocytosis of apoptotic cells, and other factors may be associated with this phagocytosis mechanism.
DISCUSSION
During phagocytosis of apoptitic cells, the mechanisms by which macrophages recognize the cell surface molecules that are expressed during apoptosis progression are under investigation. Recognition mechanisms mediated by PS, 17, 20, 21) sugar chains in the cell membrane, [22] [23] [24] and vitronectin receptors [25] [26] [27] [28] [29] have been reported. However, it is uncertain how these molecules would function in phagocytosis at each stage of apoptosis and how these molecules would relate to each other. Apoptosis is a dynamic process, during which cell surface molecules are continuously changing. In this study, we classified the apoptotic process of IFN-g-and antiFas antibody-treated HT-29 cells into three phases, and we studied the participation of each molecule expressed in each phase. Among the cell surface molecules that change during apoptosis, PS is known to increase rapidly 3) and to be related to the phagocytosis of apoptotic cells in the initial phase. 30) In our inhibition study, galactose effectively inhibited phagocytosis of apoptotic cells as well as PS liposomes; thus, galactose was considered to be related to phagocytosis. Galactose was exposed in the initial phase, and was concerned with phagocytosis in every phase, similar to PS. Neuraminidase-treated HT29 cells were also ingested by macrophages, although the phagocytosis ratio was lower than that for apoptotic cells. These results indicated that galactose was one of the important factors for phagocytosis in every phase.
In this study, our results revealed only the participation of galactose for phagocytosis, though the participation of sugar chains in the phagocytosis of apoptotic cells-galactose in thymocytes 22) and mannose and fucose in hepatocytes and neutrophils, 23, 24) has also been reported. This difference in participating sugars might be caused by differences in the plasma membrane alterations of each type of apoptotic cell used in these reports and our study. The HT-29 cells we used in this study were vigorously changed in galactose expression (compared to mannose and fucose) during the apoptotic process. Recently, several receptors have been implicated in the recognition and engulfment of apoptotic cells, and lectins related to phagocytosis on macrophages have been clarified. 31, 32) Thus, further studies will be required for these lectins, in addition to cell surface sugar chains, to clarify the participation of sugar chains in macrophage phagocytosis.
Previous studies reported the participation of PS, sugar (galactose, mannose), and vitronectin receptors in phagocytosis only in late apoptosis. However, our results showed the inhibitory effects of RGDS on the initial and metaphases but not on the later phase, though the effects of PS and sugar were observed in every phase. It was suggested that the vitronectin receptor was related to the phagocytosis of the initial and metaphases of apoptotic cells, but not the later phase. Fadok and colleagues reported that macrophage recognition of apoptotic cells was changed to the PS receptor from the vitronectin receptor during differentiation of macrophages. 33, 34) It is also necessary to carry out further research on the recognition by macrophages by adjusting their differentiation stage.
Though the ratios of phagocytosed cells were almost constant during the three apoptotic phases, the inhibitory effect of RGDS decreased in the later phase, and the effects of PS and galactose increased in metaphase and in the later phase. The phagocytosis of apoptotic cells in the later phase was more efficient than that of NEM-treated or neuraminidasetreated HT29 cells, which was almost inhibited by PS-liposomes or galactosidase, respectively (Fig. 3) . Furthermore, phagocytosis of the cells in the later phase of apoptosis was partly inhibited by PS-liposomes and sugar (Table 1) . From our inhibitory study it was suggested that PS and galactose may have a cooperative action in the phagocytosis of apoptotic cells. Thus, we examined the phagocytosis of both neuraminidase-and NEM-treated HT-29 cells, but their phagocytosis was not so high compared to that of the cells independently treated with anti-Fas Ab or neuraminidase, against our expectation (Fig. 3) . NEM-and neuraminidase-co-treated cells expressed slightly higher levels of PS and lower levels of galactose than anti-Fas Ab-treated cells. The low phagocytosis of co-treated cells may be caused by differences in PS and galactose expression levels between apoptotic HT-29 cells and our prepared cells (Fig. 2) , suggesting that other factors are involved or cooperate with PS and galactose. The phagocytosis of the cells in the later phase of apoptosis may be efficiently performed by this other recognition mechanism. Incomplete inhibition of phagocytosis by the combination of PS liposomes and galactose also supported the existence of other factors. Many molecules besides PS and galactose, such as ICAM-3, 35) are expressed on cells during apoptosis. In addition, many receptors on macrophages mediating recognition and uptake of apoptotic cells have been reported. These receptors, whose ligands are not yet proven, may be involved in phagocytosis. Future research concerning these molecules is needed. In conclusion, our findings suggest that the cell surface molecules on apoptotic cells fulfilled their roles time-dependently and cooperated in phagocytosis in vivo.
